Clinical measurement of blood flow in tumours using positron emission tomography: A review
- 1 February 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 23 (2) , 131-138
- https://doi.org/10.1097/00006231-200202000-00004
Abstract
In oncology drug development there is an increasing need for the in vivo physiological measurement of changes in tumour blood flow in response to therapy. Positron Emission Tomography (PET) is being increasingly used in oncology patients to measure blood flow. Here we review the clinical use of PET to measure vascular parameters in man.Keywords
This publication has 29 references indexed in Scilit:
- Anti-angiogenic agentsEuropean Journal Of Cancer, 2000
- CMRO2 and CBF by the Oxygen-15 Inhalation TechniqueEuropean Neurology, 1981
- Regional cerebral oxygen utilization and blood flow in normal man using oxygen-15 and positron emission tomographyActa Neurologica Scandinavica, 1980
- A theoretical study of quantitative flow measurements with constant infusion of short-lived isotopesPhysics in Medicine & Biology, 1979
- Topographical distribution of VA/Q in elderly subjects using krypton-81mRespiration Physiology, 1978
- Continuous assessment of regional myocardial perfusion in dogs using krypton-81m.Circulation Research, 1978
- Definition of myocardial perfusion by continuous infusion of krypton-81mThe American Journal of Cardiology, 1976
- Measurement of regional pulmonary oedema in man using radioactive water (H215O)The British Journal of Radiology, 1976
- The measure in vivo of regional cerebral oxygen utilization by means of oxyhemoglobin labeled with radioactive oxygen-15Journal of Clinical Investigation, 1970
- The Determination of Regional Cerebral Blood Flow by Means of Water Labeled with Radioactive Oxygen 15Radiology, 1969